Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CHRM1 is a Druggable Melanoma Target Whose Endogenous Activity is Determined by Inherited Genetic Variation in DOPA Production

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.03.433757Source: DataRank Database

CHRM1 is a Druggable Melanoma Target Whose Endogenous Activity is Determined by Inherited Genetic Variation in DOPA Production is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (14)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christopher A. Natale ORCID,In Young Lee,Swati Venkat ORCID,Sung Hoon Kim ORCID,John A. Katzenellenbogen ORCID

Live enrichment

PubMed:19965766 OpenAlex:https://openalex.org/W3135169832

National Institutes of Health

Grant: 5F31CA250316-03

Influence of Melanocyte Differentiation State on Melanoma Susceptibility

National Institutes of Health

Grant: 5R01CA163566-04

Signaling Modulators in Epidermal Carcinogenesis

National Institutes of Health

Grant: 5T32AR007465-40

DERMATOLOGY RESEARCH TRAINING GRANT

National Institutes of Health

Grant: 1R41CA228695-01

Development of GPER agonists as Cancer Therapeutics

National Institutes of Health

Grant: 5P30AR069589-03

Penn Resource-based Center to Support and Translate Skin DiseasesResearch

greenLicense: https://www.biorxiv.org/about/FAQ#license

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/07/15/2021.03.03.433757.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.03.433757

repositoryhttps://doi.org/10.1101/2021.03.03.433757

https://dx.doi.org/10.1101/2021.03.03.433757

Fields of Study

melanin and skin pigmentationReceptor Mechanisms and SignalingNeurobiology and Insect Physiology Research0301 basic medicine03 medical and health sciences

Keywords

MelanomaMelaninMelanocyteCancer researchBiologyHuman skinCellCell biologyGenetics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being